HANY MASSARANY
CIK 1134554 · President and CEO · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$451.8K
Companies
4
Total Filings
103
Lifetime Open-Market Net
-$3.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDSX | Director | 18,175 | $24.86 | $451.8K | $315.9K | 15 | 2026-01-06 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 39,891 | $0.03 | $1.4K | $119.0K | 11 | 2024-07-01 |
| GenMark Diagnostics, Inc. (GNMK) Delisted | President and CEO | 1,346,742 | $24.04 | $32.38M | -$3.78M | 73 | 2020-01-23 |
| VENTANA MEDICAL SYSTEMS INC (VMSI) Delisted | Chief Operating Officer | 37 | — | — | $0 | 4 | 2008-02-20 |
Recent Filings · Page 3 of 11
103 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-05-26 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2022-02-01 | Accelerate Diagnostics, Inc (AXDX) Delisted | Buy (P) | +20,000 | $66.0K | EDGAR |
| 2021-09-28 | Accelerate Diagnostics, Inc (AXDX) Delisted | Buy (P) | +10,000 | $53.0K | EDGAR |
| 2021-07-01 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2021-05-24 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-03 | BDSX | Mixed | +7,500 | $135.0K | EDGAR |
| 2020-01-23 | GenMark Diagnostics, Inc. (GNMK) Delisted | Mixed | +46,129 | -$141.7K | EDGAR |
| 2019-11-26 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −16,423 | -$89.2K | EDGAR |
| 2019-11-21 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −7,744 | -$43.0K | EDGAR |
| 2019-08-30 | GenMark Diagnostics, Inc. (GNMK) Delisted | Sell (S) | −16,659 | -$100.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.